REPORT ID 445

EMEA (Europe, Middle East and Africa) Nicotinamide Phosphoribosyltransferase Market Report 2017

Publish Date
01-Dec-17
Pages
101
Format
Electronic (PDF)

In this report, the EMEA Nicotinamide Phosphoribosyltransferase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Nicotinamide Phosphoribosyltransferase for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Nicotinamide Phosphoribosyltransferase market competition by top manufacturers/players, with Nicotinamide Phosphoribosyltransferase sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Genentech, Inc.
    Angelini Group
    Calico LLC
    FORMA Therapeutics, Inc.
    OncoTartis, Inc.
    Karyopharm Therapeutics, Inc.
    Aurigene Discovery Technologies Limited
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Hormone
    Lipids
    Small Molecule Compounds
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Parkinson's Disease
    Acute Lung Injury
    Breast Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Nicotinamide Phosphoribosyltransferase Market Report 2017
1 Nicotinamide Phosphoribosyltransferase Overview
    1.1 Product Overview and Scope of Nicotinamide Phosphoribosyltransferase
    1.2 Classification of Nicotinamide Phosphoribosyltransferase
        1.2.1 EMEA Nicotinamide Phosphoribosyltransferase Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Nicotinamide Phosphoribosyltransferase Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Hormone
        1.2.4 Lipids
        1.2.5 Small Molecule Compounds
        1.2.6 Others
    1.3 EMEA Nicotinamide Phosphoribosyltransferase Market by Application/End Users
        1.3.1 EMEA Nicotinamide Phosphoribosyltransferase Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Parkinson's Disease
        1.3.3 Acute Lung Injury
        1.3.4 Breast Cancer
        1.3.5 Others
    1.4 EMEA Nicotinamide Phosphoribosyltransferase Market by Region
        1.4.1 EMEA Nicotinamide Phosphoribosyltransferase Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Nicotinamide Phosphoribosyltransferase (2012-2022)
        1.5.1 EMEA Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2012-2022)

2 EMEA Nicotinamide Phosphoribosyltransferase Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Nicotinamide Phosphoribosyltransferase Market Competition by Players/Manufacturers
        2.1.1 EMEA Nicotinamide Phosphoribosyltransferase Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Nicotinamide Phosphoribosyltransferase Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Nicotinamide Phosphoribosyltransferase Sale Price by Players (2012-2017)
    2.2 EMEA Nicotinamide Phosphoribosyltransferase (Volume and Value) by Type/Product Category
        2.2.1 EMEA Nicotinamide Phosphoribosyltransferase Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Nicotinamide Phosphoribosyltransferase Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Nicotinamide Phosphoribosyltransferase Sale Price by Type (2012-2017)
    2.3 EMEA Nicotinamide Phosphoribosyltransferase (Volume) by Application
    2.4 EMEA Nicotinamide Phosphoribosyltransferase (Volume and Value) by Region
        2.4.1 EMEA Nicotinamide Phosphoribosyltransferase Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Nicotinamide Phosphoribosyltransferase Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Nicotinamide Phosphoribosyltransferase Sales Price by Region (2012-2017)

3 Europe Nicotinamide Phosphoribosyltransferase (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Nicotinamide Phosphoribosyltransferase Sales and Value (2012-2017)
        3.1.1 Europe Nicotinamide Phosphoribosyltransferase Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2012-2017)
    3.2 Europe Nicotinamide Phosphoribosyltransferase Sales and Market Share by Type
    3.3 Europe Nicotinamide Phosphoribosyltransferase Sales and Market Share by Application
    3.4 Europe Nicotinamide Phosphoribosyltransferase Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Nicotinamide Phosphoribosyltransferase Sales Volume by Countries (2012-2017)
        3.4.2 Europe Nicotinamide Phosphoribosyltransferase Revenue by Countries (2012-2017)
        3.4.3 Germany Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2017)
        3.4.4 France Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2017)
        3.4.5 UK Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2017)
        3.4.6 Russia Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2017)
        3.4.7 Italy Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2017)

4 Middle East Nicotinamide Phosphoribosyltransferase (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Nicotinamide Phosphoribosyltransferase Sales and Value (2012-2017)
        4.1.1 Middle East Nicotinamide Phosphoribosyltransferase Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2012-2017)
    4.2 Middle East Nicotinamide Phosphoribosyltransferase Sales and Market Share by Type
    4.3 Middle East Nicotinamide Phosphoribosyltransferase Sales and Market Share by Application
    4.4 Middle East Nicotinamide Phosphoribosyltransferase Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Nicotinamide Phosphoribosyltransferase Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Nicotinamide Phosphoribosyltransferase Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2017)
        4.4.4 Israel Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2017)
        4.4.5 UAE Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2017)
        4.4.6 Iran Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2017)

5 Africa Nicotinamide Phosphoribosyltransferase (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Nicotinamide Phosphoribosyltransferase Sales and Value (2012-2017)
        5.1.1 Africa Nicotinamide Phosphoribosyltransferase Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate (2012-2017)
    5.2 Africa Nicotinamide Phosphoribosyltransferase Sales and Market Share by Type
    5.3 Africa Nicotinamide Phosphoribosyltransferase Sales and Market Share by Application
    5.4 Africa Nicotinamide Phosphoribosyltransferase Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Nicotinamide Phosphoribosyltransferase Sales Volume by Countries (2012-2017)
        5.4.2 Africa Nicotinamide Phosphoribosyltransferase Revenue by Countries (2012-2017)
        5.4.3 South Africa Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Nicotinamide Phosphoribosyltransferase Sales and Growth Rate (2012-2017)

6 EMEA Nicotinamide Phosphoribosyltransferase Manufacturers/Players Profiles and Sales Data
    6.1 Genentech, Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Nicotinamide Phosphoribosyltransferase Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Angelini Group
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Nicotinamide Phosphoribosyltransferase Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Angelini Group Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Calico LLC
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Nicotinamide Phosphoribosyltransferase Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Calico LLC Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 FORMA Therapeutics, Inc.
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Nicotinamide Phosphoribosyltransferase Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 OncoTartis, Inc.
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Nicotinamide Phosphoribosyltransferase Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Karyopharm Therapeutics, Inc.
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Nicotinamide Phosphoribosyltransferase Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Aurigene Discovery Technologies Limited
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Nicotinamide Phosphoribosyltransferase Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Nicotinamide Phosphoribosyltransferase Manufacturing Cost Analysis
    7.1 Nicotinamide Phosphoribosyltransferase Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Nicotinamide Phosphoribosyltransferase

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Nicotinamide Phosphoribosyltransferase Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Nicotinamide Phosphoribosyltransferase Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Nicotinamide Phosphoribosyltransferase Market Forecast (2017-2022)
    11.1 EMEA Nicotinamide Phosphoribosyltransferase Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Nicotinamide Phosphoribosyltransferase Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Nicotinamide Phosphoribosyltransferase Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Nicotinamide Phosphoribosyltransferase Price and Trend Forecast (2017-2022)
    11.2 EMEA Nicotinamide Phosphoribosyltransferase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Nicotinamide Phosphoribosyltransferase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Nicotinamide Phosphoribosyltransferase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Nicotinamide Phosphoribosyltransferase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Nicotinamide Phosphoribosyltransferase Sales Forecast by Type (2017-2022)
    11.7 EMEA Nicotinamide Phosphoribosyltransferase Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer